|Last Price||Today's Change||52-Week Range||Trading Volume|
|121.53||-1.82 (-1.48%)||66.85 - 125.45||4.3 million|
Market data as of 4:00PM 02/27/15. Quotes are delayed by at least 15 min.
ADDING MULTIMEDIA REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant
02/20/2015 3:30 AM ET